429. Cytoreductive surgery with intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin

Abstract Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provide a promising additional treatment option for selected patients with peritoneal carcinomatosis arising from colorectal cancer. Due to the aggressive surgery the concept is associated with a significant morbidity rate. Thus, the operative risk has to be evaluated against the background of the expected improvement of the oncological outcome. J. Surg. Oncol. 2009;100:306–310. © 2009 Wiley‐Liss, Inc.

Hyperthermic Intraperitoneal Chemotherapy

Intraperitoneal Chemotherapy

10.1002/jso.21332

Cite

Citations (33)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) (2019)

Toshiyuki Kitai Soh ARITA Naoko Sugimoto Osamu Inamoto Kenya Yamanaka

目的:大腸癌腹膜播種に対する減量手術と腹腔内温熱化学療法（CRS+HIPEC）は有効な治療法であるが，高い合併症率や再発率など克服すべき問題がある．この研究の目的は，その安全性と有効性を検証することである．

Hyperthermic Intraperitoneal Chemotherapy

Intraperitoneal Chemotherapy

10.3919/jjsa.80.835

Cite

Citations (0)

Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis

世界胃肠病学杂志：英文版（电子版） (2008)

Hassan Alaa Alaa Hammed al-Shammaa Yan

这篇文章是为腹癌病(PC ) 的治疗加腹膜内的亢奋的热化疗(IPHC ) 在 cytoreductive 外科(CRS ) 的使用上提供简明评论。传统地， PC 与很差的反应和不到 6 瞬间的中部的幸存独自与全身的化疗被对待。随几阶段 II 研究的建立，当为对待的一个标准方法与 PC，足够的 cytoreduction 能在被完成选择了病人，一个新趋势向 CRS 正 IPHC 的使用被开发了。尽管有对更高质量的阶段 III 研究的需要，现在作为标准照顾在在全世界关于这新治疗策略的使用的许多外科的肿瘤学专家之中有一致为颜色有 PC 的表面的癌症病人。这评论在未来总结当前的地位和可能的进步。

Hyperthermic Intraperitoneal Chemotherapy

Intraperitoneal Chemotherapy

Source

Cite

Citations (1)

Predictors of Recurrence in Peritoneal Carcinomatosis from High Grade Malignancies after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Open Access Journal of Cancer & Oncology (2018)

Simarpreet Singh

Extensive surgical procedures like Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) despite being associated with better survival in various peritoneal surface malignancies of ovarian, colorectal, appendicular cancers yet locoregional and distant recurrence has always been an important issue.The study aimed at determining risk factors for recurrence.

Hyperthermic Intraperitoneal Chemotherapy

Intraperitoneal Chemotherapy

10.23880/oajco-16000114

Cite

Citations (2)

ASO Visual Abstract: Actual 5-Year Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis of Colorectal Origin

Annals of Surgical Oncology (2023)

Elad Sarfaty Nazanin Khajoueinejad Allen T. Yu Spiros P. Hiotis Benjamin J. Golas

Hyperthermic Intraperitoneal Chemotherapy

Surgical oncology

Intraperitoneal Chemotherapy

10.1245/s10434-023-14742-3